Comparative Study of Menstrual Blood and Systemic Blood

Comparative Study of Menstrual Blood and Systemic Blood: Quantifying the Difference

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02740816

Enrollment

Registered

2016-04-15

Start date

2016-03-31

Completion date

2017-03-31

Last updated

2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retention; Menstruation

Brief summary

The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.

Interventions

OTHERComparative blood analysis

Collection of menstrual blood and systemic blood

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Age 18-45

Exclusion criteria

* weigh less then 110 pounds * currently on a birth control method

Design outcomes

Primary

Measure	Time frame	Description
Health Markers in Systemic Blood vs. Menstrual Blood	Up to 2 months	The following biomarkers will be tested for and then compared for systemic blood and menstrual blood: * BUN * Sodium * Potassium * Chloride * Glucose * Calcium * HDL * LDL * Triglycerides * CRP * Estradiol * Ferritin * A1c * Hemoglobin * Hepatic function panel * TSH * FSH * T3

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026